RARE
Ultragenyx to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 16, 2012
Thursday, August 9, 2012 BiopharmaWatch Research 1 min read Key Takeaway: Ultragenyx to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 16, 2012
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia
Full Press Release Details
Ultragenyx to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 16, 2012.